EUCTR2005-005046-39-IT
进行中（未招募）
不适用
A randomized phase II study to assess the activity and tolerability of two regimens of metronomic oral chemotherapy methotrexate plus cyclophosphamide and cyclophosphamide plus capecitabine combined with bevacizumab in advanced breast cancer - ND
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- ISTITUTO EUROPEO DI ONCOLOGIA
- 入组人数
- 92
- 状态
- 进行中（未招募）
- 最后更新
- 14年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Pre\- or post\-menopausal women with histologically proven, locally advanced inoperable or metastatic breast carcinoma. Measurable disease, defined as at least one lesion that can be accurately measured No more than 3 previous lines of chemotherapy for advanced disease.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
排除标准
- •Presence of cerebral or leptomeningeal involvement. Previous or concomitant other malignancy except basal or squamous cell carcinoma of the skin or adequately treated in situ carcinoma of the cervix. History of allergic reactions attributed to compounds of similar chemical or biologic composition to bevacizumab or other agents used in the study.
结局指标
主要结局
未指定
相似试验
进行中（未招募）
不适用
Randomized phase II trial evaluating the activity and the tolerability of fixed dose of oxycodone and increasing dose of pregabalin versus increasing dose of oxycodone and fixed dose of pregabalin - NDpatients affected with cancer and presenting a neuropatic component in their painMedDRA version: 9.1Level: SOCClassification code 10029205Term: Nervous system disordersEUCTR2007-005222-69-ITAssociazione Progetto Oncologia UMAN.A
进行中（未招募）
不适用
A phase II randomised study to investigate the effects of Bevacizumab on cell proliferation and on pCR in patients with locally advanced operable breast cancer - NDEUCTR2005-005048-19-ITISTITUTO EUROPEO DI ONCOLOGIA120
尚未招募
2 期
A randomised phase 2 study of carboplatin with oral vinorelbine followed by maintenance therapy with oral vinorelbine or erlotinib in elderly patients with metastatic non-small cell lung cancer.on Small Cell Lung CancerNon Small Cell Lung CancerCancer - Lung - Non small cellACTRN12612000473864Southern Health100
招募中
2 期
A randomised phase II study to evaluate the effectiveness of botulinum toxin to delay, and possibly prevent, progressive foot deformities in children with Charcot-Marie-Tooth (CMT) disease.Charcot-Marie-Tooth diseaseHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersNeurological - Other neurological disordersACTRN12605000115639The Children's Hospital at Westmead10
招募中
1 期
Effects of natural seaweed extract (GFS) on mobilisation of human bone marrow stem cells and immune system activatioormal volunteersNormal volunteersOther - Research that is not of generic health relevance and not applicable to specific health categories listed aboveInflammatory and Immune System - Normal development and function of the immune systemACTRN12605000021673Tas100